汇添富国证生物医药ETF(159839)资产配置 |
|
报告日期 |
股票(元) |
债券(元) |
基金总资产(元) |
基金净值(元) |
股票占净值比 |
2024/3/31 |
480,344,000 |
- |
483,902,000 |
483,172,000 |
99% |
2023/12/31 |
540,261,000 |
- |
548,141,000 |
542,797,000 |
100% |
2023/9/30 |
607,859,000 |
- |
639,768,000 |
609,902,000 |
100% |
2023/6/30 |
684,984,000 |
- |
693,610,000 |
688,251,000 |
100% |
2023/3/31 |
521,478,000 |
- |
530,294,000 |
524,021,000 |
100% |
2022/12/31 |
451,572,000 |
- |
455,350,000 |
454,202,000 |
99% |
2022/9/30 |
397,980,000 |
- |
402,176,000 |
399,437,000 |
100% |
2022/6/30 |
338,228,000 |
- |
344,501,000 |
340,029,000 |
99% |
2022/3/31 |
340,436,000 |
- |
342,600,000 |
341,261,000 |
100% |
2021/12/31 |
338,092,000 |
- |
343,304,000 |
341,581,000 |
99% |
2021/9/30 |
271,402,000 |
- |
274,714,000 |
272,935,000 |
99% |
2021/6/30 |
261,453,000 |
119,600 |
264,318,000 |
262,492,000 |
100% |
2021/2/8 |
301,322,000 |
- |
524,146,000 |
481,706,000 |
63% |
*注:新浪财经提醒:以上数据由合作伙伴提供,仅供参考,交易请以正式公告数据为准。